A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven

[1]  L. Ousager,et al.  Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review , 2021, Orphanet Journal of Rare Diseases.

[2]  I. Chirivella,et al.  Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization , 2020, Cancers.

[3]  A. Aguilar-Shea,et al.  [Hereditary leiomyomatosis and renal cell cancer]. , 2020, Semergen.

[4]  R. Kuiper,et al.  Renal cell carcinoma in young FH mutation carriers: case series and review of the literature , 2019, Familial Cancer.

[5]  D. Evans,et al.  Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals. , 2019, European urology oncology.

[6]  H. Go,et al.  Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures , 2019, BMC Urology.

[7]  T. Shimamura,et al.  Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement , 2018, Pediatric blood & cancer.

[8]  C. Genestie,et al.  Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers , 2017, Clinical genetics.

[9]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[10]  B. Ristau,et al.  Abnormal Cystic Tumor in a Patient with Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: Evidence of a Precursor Lesion? , 2015, Case Reports in Urology.

[11]  W. Linehan,et al.  Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment , 2014, Familial Cancer.

[12]  R. Srinivasan,et al.  2008 CLINICAL FEATURES AND MANAGEMENT OF HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER (HLRCC) , 2012 .

[13]  L. Thomas,et al.  Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma , 2011, Journal of Medical Genetics.

[14]  Alison Martin,et al.  Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. , 2007, Cancer cell.

[15]  L. Aaltonen,et al.  Increased risk of cancer in patients with fumarate hydratase germline mutation , 2005, Journal of Medical Genetics.

[16]  I. Leigh,et al.  Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer , 2005, The British journal of dermatology.

[17]  N. Terada,et al.  The natural history of simple renal cysts. , 2002, The Journal of urology.